Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
324.19
+0.33 (0.10%)
May 6, 2026, 4:00 PM EDT - Market closed
Penumbra Employees
Penumbra had 4,700 employees as of December 31, 2025. The number of employees increased by 200 or 4.44% compared to the previous year.
Employees
4,700
Change (1Y)
200
Growth (1Y)
4.44%
Revenue / Employee
$309,422
Profits / Employee
$36,393
Market Cap
12.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | 200 | 4.44% |
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| DexCom | 11,100 |
| Bruker | 11,085 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
PEN News
- 14 hours ago - Penumbra, Inc. Reports First Quarter 2026 Financial Results - PRNewsWire
- 23 days ago - New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients - PRNewsWire
- 2 months ago - 8 Stocks to Buy as Merger-Mania Takes Over - Benzinga
- 2 months ago - Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 3 months ago - Boston Scientific announces results for fourth quarter and full year 2025 - PRNewsWire
- 3 months ago - Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 3 months ago - Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach - Invezz
- 3 months ago - Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. - Barrons